Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects - Kelly Kuk, Jennifer L. Taylor-Cousar, 2015
Impact of the CFTR-Potentiator Ivacaftor on Airway Microbiota in Cystic Fibrosis Patients Carrying A G551D Mutation | PLOS ONE
3 Easy Ways to Treat Cystic Fibrosis - wikiHow Health
AIM | Treatment of Cystic Fibrosis
Frontiers | Comprehensive Analysis of Chemical Structures That Have Been Tested as CFTR Activating Substances in a Publicly Available Database CandActCFTR
The magnitude of ivacaftor effects on fluid secretion via R117H-CFTR channels: Human in vivo measurements | PLOS ONE
Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure–Activity and Structure–Property Relationship Studies | Journal of Medicinal Chemistry
Ivacaftor carboxylate | C24H26N2O5 - PubChem
Elexacaftor/tezacaftor/ivacaftor - Wikipedia
Elexacaftor/tezacaftor/ivacaftor - Wikipedia
Ivacaftor (VX 770, CAS Number: 873054-44-5) | Cayman Chemical
The impact of ivacaftor on sinonasal pathology in S1251N-mediated cystic fibrosis patients | PLOS ONE
A Little CFTR Goes a Long Way: CFTR-Dependent Sweat Secretion from G551D and R117H-5T Cystic Fibrosis Subjects Taking Ivacaftor | PLOS ONE
Structural identification of a hotspot on CFTR for potentiation | Science
Elexacaftor - Wikipedia
Pyrilutamide - Wikipedia
Lumacaftor/ivacaftor - Wikipedia
Frontiers | CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects - Kelly Kuk, Jennifer L. Taylor-Cousar, 2015
Ivacaftor cystic fibrosis drug molecule. Stock Illustration | Adobe Stock
How to pronounce lumacaftor-ivacaftor | HowToPronounce.com